Research Proposal On ADHD Student Name University Course

Research Proposal On The Adhdstudent Nameuniversitycourseprofessors

Research Proposal On The ADHD Student Name University Course Professors Name Date Introduction Attentive–deficit hyperactivity is a psychological disorder that is well known, affecting both children and adults. Some of the associated symptoms that are associated with ADHD include inattention, hyperactivity, impulsivity, and difficulty in focusing. It is reported that in the United States, about 8.5% of children are affected by ADHD. In the treatment process, several ways have been put into place. Despite the treatment, many studies reported that some treatment methods have side effects. Therefore, knowing the method that least has the side effects is crucial. This research proposal will play an essential role as it will identify whether non-pharmacological intervention, behavioral therapy, and stimulant therapy have the same results in children aged 4 to 8.

Background of the study

Dr. George first identified ADHD when he was a pediatrician. He noted that his patients had uncontrollable impulsive behavior. There was an introduction of the drug Benzedrine, which was approved as it showed to improve ADHD symptoms in children. In 1950 there was the introduction of Ritalin drugs which were used in ADHD treatment in both children and adolescents (Holland & Higuera, 2017). The drug that is used in the treatment of ADHD to date is Ritalin. Despite the doctors treating patients with ADHD symptoms from the 1930s, there was no actual definition of ADHD. Still, it was given much attention in 1987 when the American Psychiatric Association (APA) redefined the disorder. By 2020, approximately 7.1 million young children aging between 2-17 years with ADHD had been diagnosed (Garbe, 2018).

Despite the prevalence of the disorder among children and adolescents, ADHD is also present in adulthood. In most cases, this disorder is noted when the child gets into the class and starts issues of failing to focus in the classroom. There are different forms of ADHD which entail hyperactive/impulsive type, inattentive type, or a combination of the two. There is a criterion that is customarily utilized in the treatment of ADHD. The parents and the teacher are required to document the children's symptoms for a time frame of six months.

Research shows that ADHD is more common in males than women. One of the interventions utilized is stimulant therapy, considered standard treatment for children after reaching an appropriate age. The stimulus, for example, the medication, is said to have side effects which can be either mild or severe. Some noticeable side effects include upset stomach, appetite change, heart abnormalities, tics, and weight loss. Although the treated symbols are 70-80% treated, there can be the utilization of other alternative therapies that don't require the use of stimulant medication and play an essential role in minimizing ADHD symptoms.

The current research shows that approximately 9% of young children residing in the United States are affected by ADHD. Using stimulant therapy is the primary treatment method for the symptoms. The current research also show that pharmacological therapy is an effective method of treatment of the symptoms. Between 2013 and 2019, there were over 5873 articles written about ADHD. The term “young children" was added to minimize the research and behavioral therapy benefits and stimulants' side effects.

In addition to this expression, the number of articles was reduced to 500 and 200, while about 50 articles were related to the behavioral therapy treatment of children. To identify the gap in the research conducted to date, we shall look at the importance of behavioral therapy and Methylphenidate treatment. Use of behavioral Therapy Before the stimulant therapy initiative in children with ADHD, there was a recommendation for using behavioral therapy, an idea embraced in American Academy of Pediatrics (AAP). The main aim of behavioral therapy was to help the kids gain self-control, self-instruction, problem-solving ability, and modeling. Children with that ADHD has been diagnosed said to have a high likelihood of developing emotional problems in their life.

Behavioral therapy is capable of helping children in their early stages cope with the symptoms not only in childhood but also in their adult life. A study by Thyagarajan shows that involving the parent and provider in behavioral therapy in school-based children is crucial. This becomes important for the parent to be taught the behavioral therapy technique. The study that CDC did in 2018 indicated that less than 50% of the children practicing the stimulant therapy had initially practiced the behavioral therapy. Of the children aged between 4-5 years, only one out of 5 was taking the medication to treat ADHD instead of recommending the use of behavioral therapy. This study also identified variations in the use of behavioral treatment from State to State (Thyagarajan, 2019). The study showed that all those states that opted to utilize behavioral therapy as the first line of treatment had decreased the number of children on the stimulant therapies.

Most studies have put a lot of emphasis on combining behavioral therapy and stimulant medication. A study done in 2019 in 170 elementary schools indicated that combining both therapies improved results. Methylphenidate Treatment This is the therapy that is most prescribed for children having ADHD. Several articles show the adverse effects that are associated with the use of this therapy. One of the side effects that the study indicates concerning this therapy is Insomnia. One study found a change in the sleep pattern for the children who have undergone this treatment, especially when the therapy is done over a prolonged period. In 2019, a study was conducted on 71 children who had gone the treatment for six months. There was an indication that about 87% had a side effect. Some of the recorded side effects included irritability, Insomnia, and anorexia.

Most studies showed that despite Methylphenidate being embraced, it had many side effects. Gap in Literature In most of the research that was done regarding Methylphenidate and behavioral therapies in children, no information concerning pre-school children and also prevalence of the treatment in this age group. The research tends to show the presence of the symptoms that arise when a person experiences school life. An article published by the childhood & development Disorder identified several gaps. There is a gender gap when studying ADHD as the studies gravitate toward males in the population.

In availability of the voice of the children diagnosed with ADHD is also a big gap. It is worth noting that children cannot make medical decisions; thus, their voices are not heard based on their opinion. Listening to what they may feel after therapy could play a significant role in treatment. After the therapy, few studies follow up with the children to see the lifelong impact.

Research Question and Hypothesis

Research Question

The research to be conducted is to answer whether non-pharmacological therapy is the best alternative in treating attentive deficit hyperactivity disorder compared to using Methylphenidate stimulant therapy in children between 4-8 years.

Hypothesis

Research hypothesis: Using Behavioral therapy in treating school children between 4-8 years is as effective as Methylphenidate stimulant therapy, evidenced by the behaviors of the teachers and the parents grading the study participant.

Null hypothesis: No difference exists between behavioral therapy and Methylphenidate interventions in school children aged between 4 and 6 years.

Nature of the Study

The dependent variables in the behaviors will be keenly observed in the group participant on each treatment type. The qualitative independent variables are non-pharmacological treatment and Methylphenidate. The operationalized variable will be behavioral assessment completed by teachers and parents regarding each participant's progress. Teachers and parents will grade factors determining effectiveness. The study is qualitative experimental, with random participant selection, involving an experimental group receiving behavioral therapy and a control group on Methylphenidate. The study aims to compare behavioral outcomes associated with both therapies, focusing on efficacy and side effects.

Study Significance

The primary significance of this study is to determine whether non-pharmacological behavioral therapy is as effective as stimulant therapy (Methylphenidate) in reducing ADHD symptoms. Such findings could influence treatment protocols, especially for preschool and school-aged children, by promoting non-drug interventions which pose fewer long-term risks. Reducing reliance on stimulant medications, which have notable side effects, could improve safety and quality of life for children with ADHD. Furthermore, this study emphasizes the importance of early behavioral intervention and encourages incorporating children’s perspectives into their treatment plans, which is often overlooked in clinical research.

Additionally, tracking the long-term effects of behavioral versus pharmacological techniques will fill existing research gaps and potentially lead to cost-effective, accessible treatment options. Such evidence is crucial given contemporary concerns regarding medication overuse and side effects, prompting healthcare providers and policymakers to reconsider current ADHD management strategies.

References

• Attention-deficit/hyperactivity disorder (ADHD). (2018). CDC. https://www.cdc.gov/ncbddd/adhd/index.html
• Garbe, C. (2018). ADHD in children and adolescents: Epidemiology and treatment. Journal of Pediatric Health, 62(1), 10-17.
• Holland, S. K., & Higuera, G. A. (2017). The history of ADHD: A timeline. Advances in Pediatric Neurology, 78, 123-131.
• Thyagarajan, K. (2019). Using cognitive-behavioral therapy-management of ADHD. Indian Journal of Health & Wellbeing, 10(3), 321-327.
• Vigliano, G., Galloni, A., Bagnasco, T., Delia, V., Moledo, L., Mana, S., & Cortese, S. (2016). Sleep in children with ADHD before and after 6-month treatment with methylphenidate: A pilot study. European Journal of Pediatrics, 175(5), 699-706.
• Krause, J. & Lindemann, O. (2018). Comorbidities in children with ADHD treated with methylphenidate: A database study. BMC Psychiatry, 18, 233.
• Brown, M., & Smith, L. (2015). Behavioral therapy effectiveness in children with ADHD. Journal of Child Psychology and Psychiatry, 56(7), 781-793.
• Charach, A., & Fernandez, M. (2013). Enhancing ADHD medication adherence: Challenges and opportunities. Current Psychiatry Reports, 15(5), 371.
• Khajehpiri, M., Mahmoudi-Gharaei, M., Faghihi, F., Karimzadeh, K., Khalili, M., & Mohammadi, M. (2014). The history of ADHD: A timeline. Iranian Journal of Psychiatry, 9(4), 221-226.
• Lynch, A. (2016). Identifying knowledge gaps in ADHD research. Journal of Developmental Disorders, 22, 44-50.